Home › Categories › Health & Wellness› Prescribing Information

Prescribing Information.pdf

belsomra_pi.pdf
Preview of Prescribing Information
🔗 Source: merck.com
📊 Size: 373 KB
📄 Pages: 23 pages
⬇️ Downloads: 58

Summary

BELSOMRA (suvorexant) is indicated for insomnia treatment, characterized by difficulties with sleep onset and/or sleep maintenance. The recommended dose is 10 mg, taken once per night within 30 minutes of going to bed, with at least 7 hours remaining before awakening. The dose can be increased to 20 mg if the 10 mg dose is well-tolerated but not effective. BELSOMRA is contraindicated in patients with narcolepsy and has warnings and precautions for CNS depressant effects, worsening of depression/suicidal ideation, complex sleep behaviors, and sleep paralysis. Common adverse reactions include somnolence.

Download File

Description

BELSOMRA (suvorexant) is indicated for insomnia treatment, characterized by difficulties with sleep onset and/or sleep maintenance.

Technical Information

  • File Format: PDF
  • File Size: 373 KB
  • Pages: 23
  • Language: EN
  • Total Downloads: 58
  • Last Updated: 2 weeks ago

Document Overview

This PDF document about Prescribing Information provides comprehensive information and guidance. Whether you're a beginner or advanced user, this resource offers valuable insights into Prescribing Information.

Related Topics

If you're interested in Prescribing Information, you might also want to explore:

Prescribing guidePrescribing tutorialInformation guideInformation tutorial

Related Categories

Business & Finance
41204 documents
Education & Learning
22711 documents
Technology
4783 documents

Related Documents

Preview of Prescribing Information
PDF file

Prescribing Information

372 KBEN29 pages
LUPRON DEPOT-PED is a gonadotropin-releasing hormone (GnRH) agonist indicated for the treatment of pediatric patients with central precocious puberty.
Download
Preview of Prescribing Information
PDF file

Prescribing Information

1.11 MBRigobello ChiaraEN30 pages
ZILBRYSQ (zilucoplan) is a complement inhibitor for subcutaneous use, initially approved in the US in 2023.
Download
Preview of Prescribing Information
PDF file

Prescribing Information

162 KBMary FisherEN11 pages
PedvaxHIB is a Haemophilus b Conjugate Vaccine that combines a highly purified capsular polysaccharide (PRP) of Haemophilus influenzae type b with an...
Download
Preview of Prescribing Information
PDF file

Prescribing Information

1.19 MBEN2 pages
Mebeverine HCl 200mg capsules are used for symptomatic relief of irritable bowel syndrome (IBS).
Download
Preview of Prescribing Information
PDF file

Prescribing Information

1.18 MBHuffman LinaEN40 pages
FINTEPLA (fenfluramine) oral solution is indicated for treating seizures associated with Dravet syndrome and Lennox-Gastaut syndrome in patients 2...
Download

Download Prescribing Information eBooks for free and learn more about Prescribing Information. These books contain exercises and tutorials to improve your practical skills, at all levels!

Not satisfied with this document? We have related documents to Prescribing Information, try searching with similar keywords: Abiraterone Prescribing Information, Acthrel Prescribing Information, Adalat Cc Prescribing Information, Adalimumab Prescribing Information, Afinitor Prescribing Information, Afluria Prescribing Information, Alimta Prescribing Information ... Eli Lilly, Annotated Prescribing Information Pas 25sept08 Tendon

You can download PDF versions of the user's guide, manuals and ebooks about Prescribing Information, you can also find and download for free A free online manual (notices) with beginner and intermediate, Downloads Documentation, You can download PDF files (or DOC and PPT) about Prescribing Information for free, but please respect copyrighted ebooks.